Resultados de procura - Funda Meric‐Bernstam

Limitar resultados
  1. 1
    Targeting AKT for cancer therapy

    Targeting AKT for cancer therapy por Maryam Shariati, Funda Meric‐Bernstam

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Personalized cancer therapy—leveraging a knowledge base for clinical decision-making

    Personalized cancer therapy—leveraging a knowledge base for clinical decision-making por Ecaterina Ileana Dumbrava, Funda Meric‐Bernstam

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Targeting the mTOR Signaling Network for Cancer Therapy

    Targeting the mTOR Signaling Network for Cancer Therapy por Funda Meric‐Bernstam, Ana M. González-Angulo

    Publicado 2009
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Metformin: A Therapeutic Opportunity in Breast Cancer

    Metformin: A Therapeutic Opportunity in Breast Cancer por Ana M. González-Angulo, Funda Meric‐Bernstam

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Accuracy and self correction of information received from an internet breast cancer list: content analysis

    Accuracy and self correction of information received from an internet breast cancer list: content analysis por Adol Esquivel, Funda Meric‐Bernstam, Elmer V. Bernstam

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

    Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway por B. Hassan, Argun Akçakanat, Ashley M. Holder, Funda Meric‐Bernstam

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Hepatocellular carcinoma: Where there is unmet need

    Hepatocellular carcinoma: Where there is unmet need por Manojkumar Bupathi, Ahmed O. Kaseb, Funda Meric‐Bernstam, Aung Naing

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Building a Personalized Medicine Infrastructure at a Major Cancer Center

    Building a Personalized Medicine Infrastructure at a Major Cancer Center por Funda Meric‐Bernstam, Carol Farhangfar, John Mendelsohn, Gordon B. Mills

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    State-of-the-Art Strategies for Targeting <i>RET</i>-Dependent Cancers

    State-of-the-Art Strategies for Targeting <i>RET</i>-Dependent Cancers por Vivek Subbiah, Dong Yang, Vamsidhar Velcheti, Alexander Drilon, Funda Meric‐Bernstam

    Publicado 2020
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical Experience

    Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical Experience por James C. Yao, Alexandria T. Phan, Valentine Jehl, Gaurav Shah, Funda Meric‐Bernstam

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    PurityEst: estimating purity of human tumor samples using next-generation sequencing data

    PurityEst: estimating purity of human tumor samples using next-generation sequencing data por Xiaoping Su, Li Zhang, Jianping Zhang, Funda Meric‐Bernstam, John N. Weinstein

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Antibody-drug conjugates in lung cancer: dawn of a new era?

    Antibody-drug conjugates in lung cancer: dawn of a new era? por Niamh Coleman, Timothy A. Yap, John V. Heymach, Funda Meric‐Bernstam, Xiuning Le

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features

    CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features por Yong Mao, Han Chen, Han Liang, Funda Meric‐Bernstam, Gordon B. Mills, Ken Chen

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer

    Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer por Su Seong Woo, Takafumi Sangai, Argun Akçakanat, H. Chen, C. Wei, Funda Meric‐Bernstam

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases

    Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases por Argun Akçakanat, Ayşegül A. Şahin, Alexandra N. Shaye, Marco A. De Velasco, Funda Meric‐Bernstam

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Commonly cited website quality criteria are not effective at identifying inaccurate online information about breast cancer

    Commonly cited website quality criteria are not effective at identifying inaccurate online information about breast cancer por Elmer V. Bernstam, Muhammad F. Walji, Smitha Sagaram, Deepak Sagaram, Craig Johnson, Funda Meric‐Bernstam

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors

    Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors por Amy C. Moreno, Argun Akçakanat, Mark F. Munsell, Ajay Soni, J.C. Yao, Funda Meric‐Bernstam

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Bias from removing read duplication in ultra-deep sequencing experiments

    Bias from removing read duplication in ultra-deep sequencing experiments por Wanding Zhou, Tenghui Chen, Hao Zhao, Agda Karina Eterovic, Funda Meric‐Bernstam, Gordon B. Mills, Ken Chen

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Challenges and perspective of drug repurposing strategies in early phase clinical trials

    Challenges and perspective of drug repurposing strategies in early phase clinical trials por Shumei Kato, Stacy L. Moulder, Naoto T. Ueno, Jennifer J. Wheler, Funda Meric‐Bernstam, Razelle Kurzrock, Filip Janků

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Strategies for improving the management of immune-related adverse events

    Strategies for improving the management of immune-related adverse events por Aung Naing, Joud Hajjar, James L. Gulley, Michael B. Atkins, Gennaro Ciliberto, Funda Meric‐Bernstam, Patrick Hwu

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: